Sage Therapeutics, Inc.
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.
Last Closing Price
November 15, 2017
J.P. Morgan, Goldman Sachs, Morgan Stanley
To view the prospectus for Sage Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277